These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7251404)

  • 21. Characterization of acatalasemic erythrocytes treated with low and high dose hydrogen peroxide. Hemolysis and aggregation.
    Masuoka N; Sugiyama H; Ishibashi N; Wang DH; Masuoka T; Kodama H; Nakano T
    J Biol Chem; 2006 Aug; 281(31):21728-21734. PubMed ID: 16751193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THE CATALASE PROTEIN OF ACATALASEMIC AND HYPOCATALASEMIC RED BLOOD CELLS. II. SPECTROPHOTOMETRIC STUDY.
    TAKAHARA S; OGATA M
    Acta Med Okayama (1952); 1964 Feb; 18():9-14. PubMed ID: 14201063
    [No Abstract]   [Full Text] [Related]  

  • 23. THE CATALASE PROTEIN OF ACATALASEMIC AND HYPOCATALASEMIC RED BLOOD CELLS. I. QUANTITATIVE PRECIPITIN STUDIES ON HEMOLYSATE AND ACETONE EXTRACT.
    OGATA M; TAKAHARA S
    Acta Med Okayama (1952); 1964 Feb; 18():1-8. PubMed ID: 14201060
    [No Abstract]   [Full Text] [Related]  

  • 24. Methemoglobin formation in the blood of Japanese subjects and mice suffering from acatalasemia in response to methemoglobin inducers.
    Ogata M; Ishii K; Ioku N; Meguro T
    Physiol Chem Phys Med NMR; 1990; 22(3):125-34. PubMed ID: 2093192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further genetic heterogeneity in acatalasemia.
    Góth L
    Electrophoresis; 1997 Oct; 18(11):1942-3. PubMed ID: 9420149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hungarian hereditary acatalasemia and hypocatalasemia are not associated with chronic hemolysis.
    Góth L; Vitai M
    Clin Chim Acta; 1995 Jan; 233(1-2):75-9. PubMed ID: 7758204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 3-amino-1,2,4-triazole on mercury uptake by in vitro human blood samples and by whole rats.
    Magos L; Sugata Y; Clarkson TW
    Toxicol Appl Pharmacol; 1974 Jun; 28(3):367-73. PubMed ID: 4851792
    [No Abstract]   [Full Text] [Related]  

  • 28. The oxidation of metallic mercury by catalase in relation to acatalasemia.
    Ogata M; Aikoh H
    Ind Health; 1983; 21(4):219-30. PubMed ID: 6317620
    [No Abstract]   [Full Text] [Related]  

  • 29. Methanol metabolism in acatalasemic mice.
    Karinje KU; Ogata M
    Physiol Chem Phys Med NMR; 1990; 22(4):193-8. PubMed ID: 2129307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a protease inhibitor on the stability of catalase in liver and blood from acatalasemic and normal mice.
    Suzuki K; Ogata M
    Acta Med Okayama; 1991 Oct; 45(5):363-9. PubMed ID: 1755340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human residual catalase of an acatalasemic patient by isoelectric focusing and sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by electrophoretic blotting and immunodetection.
    Ogata M; Suzuki K; Satoh Y
    Electrophoresis; 1989 Mar; 10(3):194-8. PubMed ID: 2651112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of catalase subfractions separated by chromatofocusing of acatalasemia hemolysates.
    Ogata M; Mizugaki J
    Acta Med Okayama; 1982 Feb; 36(1):73-6. PubMed ID: 7064736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mercury uptake by acatalasemia mice and their erythrocytes, lung and liver homogenates.
    Ogata M; Ikeda M
    Int Arch Occup Environ Health; 1978 Mar; 41(2):87-93. PubMed ID: 631910
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of hydrogen peroxide on normal and acatalasemic mouse erythrocytes.
    Masuoka N; Zukeran A; Takemoto K; Wang DH; Ishihara K
    Toxicol Rep; 2020; 7():282-287. PubMed ID: 32071881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro enhancement of erythrocyte merucry uptake by spironolactone.
    Kushlan MC; Haddow JE; Lester R
    Toxicol Appl Pharmacol; 1975 Mar; 31(3):527-33. PubMed ID: 1145636
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitory effects of prior low-dose X-ray irradiation on carbon tetrachloride-induced hepatopathy in acatalasemic mice.
    Yamaoka K; Kataoka T; Nomura T; Taguchi T; Wang DH; Mori S; Hanamoto K; Kira S
    J Radiat Res; 2004 Mar; 45(1):89-95. PubMed ID: 15133295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjustment function among antioxidant substances in acatalasemic mouse brain and its enhancement by low-dose X-ray irradiation.
    Yamaoka K; Nomura T; Wang DH; Mori S; Taguchi T; Ishikawa T; Hanamoto K; Kira S
    Physiol Chem Phys Med NMR; 2002; 34(2):133-44. PubMed ID: 12841330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of post low-dose X-ray irradiation on carbon tetrachloride-induced acatalasemic mice liver damage.
    Kataoka T; Nomura T; Wang DH; Taguchi T; Yamaoka K
    Physiol Chem Phys Med NMR; 2005; 37(2):109-26. PubMed ID: 17022372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator.
    Reddy JK; Rao S; Moody DE
    Cancer Res; 1976 Apr; 36(4):1211-7. PubMed ID: 177202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice.
    Kikumoto Y; Sugiyama H; Inoue T; Morinaga H; Takiue K; Kitagawa M; Fukuoka N; Saeki M; Maeshima Y; Wang DH; Ogino K; Masuoka N; Makino H
    Biochim Biophys Acta; 2010 Feb; 1802(2):240-6. PubMed ID: 19883754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.